Growth Metrics

Trinity Biotech (TRIB) Treasury Shares (2016 - 2025)

Trinity Biotech's Treasury Shares history spans 10 years, with the latest figure at $24.9 million for Q4 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $24.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.9 million, a 0.0% change, with the full-year FY2025 number at $24.9 million, changed 0.0% from a year prior.
  • Treasury Shares hit $24.9 million in Q4 2025 for Trinity Biotech, up from -$24.9 million in the prior quarter.
  • Over the last five years, Treasury Shares for TRIB hit a ceiling of $24.9 million in Q4 2024 and a floor of -$24.9 million in Q1 2021.
  • Historically, Treasury Shares has averaged -$17.3 million across 5 years, with a median of -$24.9 million in 2021.
  • Biggest five-year swings in Treasury Shares: changed 0.0% in 2021 and later soared 150.38% in 2023.
  • Tracing TRIB's Treasury Shares over 5 years: stood at -$24.9 million in 2021, then changed by 0.0% to -$24.9 million in 2022, then soared by 150.38% to $12.6 million in 2023, then skyrocketed by 98.49% to $24.9 million in 2024, then changed by 0.0% to $24.9 million in 2025.
  • Business Quant data shows Treasury Shares for TRIB at $24.9 million in Q4 2025, -$24.9 million in Q2 2025, and $24.9 million in Q4 2024.